An international cannabis study survey showed that almost 90 per cent of cannabis consumers partake in some kind of higher-risk consumption behaviour, such as using high-potency products or smoking as the main way of consumption, which is considered high-risk because of its harmful effects on the respiratory system.
What these studies tell us about inhalation is clouded by the judgement of those burdened by overt precautionary principle. I get that. Inhalation of high potency is smoking harm reduction, while the harmful effects are next to nothing compared to the scale of harms from tobacco or alcohol. Indeed a study by Dr Donald Tashkin (NIDA) using data that measured harms at a consumption level of a 'heavy user' = >10,000 joints over ten years, showed negligible harm and some measurable although somewhat surprising prophylactic effect regarding cancer.
When it comes to education, it must have credibility. "High Risk" is gilding the Lily.
--
What these studies tell us about inhalation is clouded by the judgement of those burdened by overt precautionary principle. I get that. Inhalation of high potency is smoking harm reduction, while the harmful effects are next to nothing compared to the scale of harms from tobacco or alcohol. Indeed a study by Dr Donald Tashkin (NIDA) using data that measured harms at a consumption level of a 'heavy user' = >10,000 joints over ten years, showed negligible harm and some measurable although somewhat surprising prophylactic effect regarding cancer.
When it comes to education, it must have credibility. "High Risk" is gilding the Lily.
--
Blair Anderson
Social Ecologist 'at large'
Christchurch, New Zealand
ph nz (643) 389 4065 nz cell 021 823647
ph nz (643) 389 4065 nz cell 021 823647
No comments:
Post a Comment